Surviving the storm: Dealing with COVID-19

por Vandenbark, Arthur A., Meza-Romero, Roberto, Offner, Halina
Publicado 2020

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury

por Vandenbark, Arthur A., Meza-Romero, Roberto, Benedek, Gil, Offner, Halina
Publicado 2019

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection

por Benedek, Gil, Meza-Romero, Roberto, Jordan, Kelley, Keenlyside, Lucy, Offner, Halina, Vandenbark, Arthur A.
Publicado 2015

Sex-dependent treatment of chronic EAE with partial MHC class II constructs

por Benedek, Gil, Chaudhary, Priya, Meza-Romero, Roberto, Calkins, Evan, Kent, Gail, Offner, Halina, Bourdette, Dennis, Vandenbark, Arthur A.
Publicado 2017

Spleen participation in partial MHC class II construct neuroprotection in stroke

por Brown, John, Kingsbury, Chase, Lee, Jea‐Young, Vandenbark, Arthur A., Meza‐Romero, Roberto, Offner, Halina, Borlongan, Cesar V.
Publicado 2020

Characterization of human platelet binding of recombinant T cell receptor ligand

por Itakura, Asako, Aslan, Joseph E, Sinha, Sushmita, White-Adams, Tara C, Patel, Ishan A, Meza-Romero, Roberto, Vandenbark, Arthur A, Burrows, Gregory G, Offner, Halina, McCarty, Owen JT
Publicado 2010